A Phase 3 Study of Efficacy and Safety of AK101 in Subjects With Psoriasis

Clinical trial NCT05120297 · COMPLETED

Trial details

NCT number: NCT05120297
Sponsor: Akeso
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Psoriasis Vulgaris

Start date: 2021-11-29
Primary completion: 2022-09-29
Enrollment: 452

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.